Stock & Company Details
Atea Pharmaceuticals Inc $AVIR
Price:
N/A
N/A
80M
$413M
52 Week High:
N/A
10 Day Average Volume:
N/A
-2.43
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
AVIR technical indicators
Latest Atea Pharmaceuticals Inc (AVIR) indicator readings as of 2026-10-09.
AVIR's 14-day RSI is 47.1, in neutral territory. At $5.15 it is trading 5.9% above its 200-day moving average of $4.86, and below its 50-day average of $5.25. Price sits in the middle of its Bollinger Bands ($4.95 to $5.49). ADX reads 13.2, indicating a range-bound market rather than a trend.
Overview
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
Finance Bot
Ask your questions
Start by typing a question below.
